Sakina Shaikh
Overview
Explore the profile of Sakina Shaikh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhatt A, Villeneuve L, Sardi A, Souadka A, Buseck A, Moran B, et al.
Ann Surg Oncol
. 2024 Aug;
31(13):8560-8571.
PMID: 39187665
Background: The PRECINCT (Pattern of peritoneal dissemination and REsponse to systemic Chemotherapy IN Common and uncommon peritoneal Tumors) is a prospective, multicenter, observational study. This report from phase I of...
2.
Sinukumar S, Damodaran D, Ray M, Prabhu A, Katdare N, Vikram S, et al.
Indian J Surg Oncol
. 2023 Jun;
14(Suppl 1):74-81.
PMID: 37359936
Supplementary Information: The online version contains supplementary material available at 10.1007/s13193-022-01640-5.
3.
Sinukumar S, Ray M, Damodaran D, Katdare N, Vikram S, Shaikh S, et al.
Indian J Surg Oncol
. 2023 Jun;
14(Suppl 1):82-91.
PMID: 37359921
The aim of the present study was to report the clinical outcome and factors affecting survival in patients with first recurrence of AGC treated with cytoreductive surgery with or without...
4.
Sinukumar S, Kammar P, Ray M, Shaikh S, Patel A, Rajan F, et al.
Indian J Surg Oncol
. 2023 Jun;
14(Suppl 1):198-208.
PMID: 37359912
Supplementary Information: The online version contains supplementary material available at 10.1007/s13193-023-01727-7.
5.
Bhatt A, Sinukumar S, Kepenekian V, Kammar P, Mehta S, Shaikh S, et al.
Front Oncol
. 2022 Sep;
12:951419.
PMID: 36119509
Background: Aggressive locoregional therapies like hyperthemic intraperitoneal chemotherapy(HIPEC) and total parietal peritonectomy(TPP) have been used to delay recurrence in patients with advanced ovarian cancer undergoing interval cytoreductive surgery(CRS). The aim...
6.
Mehta S, Kammar P, Patel A, Goswami G, Shaikh S, Sukumar V, et al.
Indian J Surg Oncol
. 2022 Sep;
:1-9.
PMID: 36091624
Taxanes have a favorable pharmacokinetic profile for intraperitoneal application. We report our initial experience with taxane-PIPAC (pressurized intraperitoneal chemotherapy) for unresectable peritoneal metastases from different primary sites in terms of...
7.
Bhatt A, Kammar P, Rousset P, Sinukumar S, Mehta S, Parkih L, et al.
Eur J Surg Oncol
. 2021 May;
47(11):2925-2932.
PMID: 34030922
Background And Aim: The greater omentum(GO) is a common site of residual disease in patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer. The presence of tumor in the GO...
8.
Bhatt A, Sinukumar S, Parikh L, Mehta S, Shaikh S, Jumle N, et al.
Eur J Surg Oncol
. 2021 Apr;
47(8):2150-2157.
PMID: 33875284
Background: The reported incidence of platinum resistant recurrence (PRR) (recurrence within 6 months of the last dose of platinum therapy) after interval debulking/cytoreductive surgery (CRS) is high compared to that...
9.
Shah S, Bhatt A, Solanki R, Thakkar N, Shaikh S, Patel M
Indian J Surg Oncol
. 2020 Dec;
11(4):589-596.
PMID: 33299277
Recent advances in minimal access/invasive surgeries in head and neck (robotic/endoscopic assisted) allow neck dissection without a visible scar through a retroauricular approach unlike conventional approach giving visible scar and...
10.
Bhatt A, Rousset P, Benzerdjeb N, Kammar P, Mehta S, Parikh L, et al.
Ann Surg Oncol
. 2020 Nov;
28(7):3840-3849.
PMID: 33210270
Background: Patients undergoing cytoreductive surgery for colorectal peritoneal metastases who have a pathologic complete response (pCR) to neoadjuvant chemotherapy experience a significantly longer survival than those with residual disease. This...